A phase II/III trial of Epidiolex in patients with infantile spasms
Phase of Trial: Phase II/III
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Registrational; Therapeutic Use
- Sponsors GW Pharmaceuticals
- 04 Dec 2017 According to a GW Pharmaceuticals media release, data from this study is expected in Q1 2018.
- 05 Dec 2016 Status changed from planning to recruiting, according to a GW Pharmaceuticals media release.
- 24 Jun 2016 New trial record